834 related articles for article (PubMed ID: 18953846)
21. Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease.
Carod-Artal FJ; Ziomkowski S; Mourão Mesquita H; Martínez-Martin P
Parkinsonism Relat Disord; 2008; 14(2):102-8. PubMed ID: 17719828
[TBL] [Abstract][Full Text] [Related]
22. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
Santos-García D; de la Fuente-Fernández R
J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
[TBL] [Abstract][Full Text] [Related]
23. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
Grosset KA; Grosset DG
Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
[TBL] [Abstract][Full Text] [Related]
24. Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease.
Pedersen KF; Larsen JP; Aarsland D
Parkinsonism Relat Disord; 2008; 14(3):183-6. PubMed ID: 17889589
[TBL] [Abstract][Full Text] [Related]
25. Depressive symptoms impacting on health-related quality of life in early Parkinson's disease: results from Chinese L-dopa exposed cohort.
Qin Z; Zhang L; Sun F; Liu H; Fang X; Chan P;
Clin Neurol Neurosurg; 2009 Nov; 111(9):733-7. PubMed ID: 19665835
[TBL] [Abstract][Full Text] [Related]
26. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.
Nègre-Pagès L; Grandjean H; Lapeyre-Mestre M; Montastruc JL; Fourrier A; Lépine JP; Rascol O;
Mov Disord; 2010 Jan; 25(2):157-66. PubMed ID: 19950403
[TBL] [Abstract][Full Text] [Related]
27. Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study.
Rektorova I; Balaz M; Svatova J; Zarubova K; Honig I; Dostal V; Sedlackova S; Nestrasil I; Mastik J; Bares M; Veliskova J; Dusek L
Clin Neuropharmacol; 2008; 31(5):261-6. PubMed ID: 18836343
[TBL] [Abstract][Full Text] [Related]
28. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
[TBL] [Abstract][Full Text] [Related]
29. Apathy and depression in Parkinson's disease: the Belgrade PD study report.
Ziropadja Lj; Stefanova E; Petrovic M; Stojkovic T; Kostic VS
Parkinsonism Relat Disord; 2012 May; 18(4):339-42. PubMed ID: 22166396
[TBL] [Abstract][Full Text] [Related]
30. [Risk factors associated to the presentation of episodes of major depression in a population of outpatients with Parkinson's disease].
Chaná-Cuevas P; Juri-Claverías C; Alburquerque D; Soto-Olmedo MJ; Benavides-Canales O
Rev Neurol; 2006 May 1-15; 42(9):521-4. PubMed ID: 16676274
[TBL] [Abstract][Full Text] [Related]
31. Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson's disease.
Montel S; Bonnet AM; Bungener C
J Geriatr Psychiatry Neurol; 2009 Jun; 22(2):95-102. PubMed ID: 19150974
[TBL] [Abstract][Full Text] [Related]
32. Depressive symptoms in Parkinson's disease.
Piccinni A; Marazziti D; Veltri A; Ceravolo R; Ramacciotti C; Carlini M; Del Debbio A; Schiavi E; Bonuccelli U; Dell'Osso L
Compr Psychiatry; 2012 Aug; 53(6):727-31. PubMed ID: 22209634
[TBL] [Abstract][Full Text] [Related]
33. [Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study].
Martínez-Martín P; Prieto-Jurczynska C; Frades-Payo B
Rev Neurol; 2009 Oct 16-31; 49(8):393-8. PubMed ID: 19816841
[TBL] [Abstract][Full Text] [Related]
34. Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson's disease.
Kummer A; Cardoso F; Teixeira AL
Mov Disord; 2008 Sep; 23(12):1739-43. PubMed ID: 18661550
[TBL] [Abstract][Full Text] [Related]
35. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease.
Martinez-Martin P; Visser M; Rodriguez-Blazquez C; Marinus J; Chaudhuri KR; van Hilten JJ; ;
Mov Disord; 2008 Sep; 23(12):1681-8. PubMed ID: 18709672
[TBL] [Abstract][Full Text] [Related]
36. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
[TBL] [Abstract][Full Text] [Related]
37. Comparative responsiveness of Parkinson's disease scales to change over time.
Schrag A; Spottke A; Quinn NP; Dodel R
Mov Disord; 2009 Apr; 24(6):813-8. PubMed ID: 19199355
[TBL] [Abstract][Full Text] [Related]
38. Validation and cross-cultural adjustment of PDQL-questionnaire, Spanish version (Ecuador) (PDQL-EV).
Serrano-Dueñas M; Martínez-Martín P; Vaca-Baquero V
Parkinsonism Relat Disord; 2004 Oct; 10(7):433-7. PubMed ID: 15465402
[TBL] [Abstract][Full Text] [Related]
39. Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease.
Ehrt U; Brønnick K; Leentjens AF; Larsen JP; Aarsland D
Int J Geriatr Psychiatry; 2006 Mar; 21(3):252-8. PubMed ID: 16477585
[TBL] [Abstract][Full Text] [Related]
40. [Burden and related factors among care-takers of patients with Parkinson's disease].
He HY; Zhou MZ; Lu LX; Wu JY; Gan J; Chen W; Liu ZG
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jun; 31(6):692-5. PubMed ID: 21163106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
